• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声造影肝脏影像报告和数据系统分类与肝细胞癌-胆管癌合并症分化程度之间的相关性

The correlation between contrast-enhanced ultrasound Liver Imaging Reporting and Data System classification and differentiation grades of combined hepatocellular carcinoma-cholangiocarcinoma.

作者信息

Yang Jingwen, Cao Jiazhi, Ruan Xiaomiao, Ren Youxiang, Ling Wenwu

机构信息

Department of Medical Ultrasound, West China Hospital of Sichuan University, Chengdu, China.

出版信息

Quant Imaging Med Surg. 2025 Jan 2;15(1):259-271. doi: 10.21037/qims-24-1483. Epub 2024 Dec 23.

DOI:10.21037/qims-24-1483
PMID:39838993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11744172/
Abstract

BACKGROUND

The contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) classification offers a framework for risk stratification in evaluating liver lesions in patients at risk for hepatocellular carcinoma (HCC). However, its clinical utility in combined HCC-cholangiocarcinoma (cHCC-CCA) has been less extensively studied. The degree of tumor differentiation is clinically significant in determining prognosis, making the analysis of imaging features across different differentiation levels essential. Additionally, studies indicate a correlation between the proportion of HCC and intrahepatic cholangiocarcinoma (ICC) components in cHCC-CCA lesions and their corresponding imaging characteristics. Therefore, the aim of this study was to assess the association of CEUS LI-RADS with the histopathological components and degree of differentiation in cHCC-CCA.

METHODS

Medical records and CEUS images of patients with cHCC-CCA pathologically confirmed between April 2020 and April 2023 were reviewed. The predominance and degree of differentiation of HCC and ICC components in cHCC-CCA were analyzed via histopathological examination. The chi-square test and two-tailed Student -test were employed to compare differences in general clinical characteristics, ultrasound features, and LI-RADS classification across various levels of differentiation and pathological components.

RESULTS

A total of 47 patients with cHCC-CCA were included in this study, comprising 39 men and 8 women, with a mean age of 56.2±8.5 years. A total of 47 lesions were analyzed. These lesions were classified according to the degree of differentiation from lower to higher as follows: poorly differentiated in 20 lesions (42.6%), moderately-poorly differentiated in 17 lesions (36.2%), and moderately differentiated in 10 lesions (21.3%). The CEUS features of lesions with varying degrees of differentiation were analyzed. It was observed that lower degrees of differentiation were associated with more pronounced early washout (P=0.028) and an increased likelihood of being classified as LR-M category under the CEUS LI-RADS classification system (P=0.043). Based on the predominance of pathological components, 36 lesions were pathologically confirmed as HCC predominant, and 11 lesions were confirmed as ICC predominant. Their ultrasound characteristics were analyzed, revealing that ICC-predominant cHCC-CCA lesions were more likely to exhibit regular shape (P=0.013) and well defined margins (P=0.010) and have an early onset of washout (P=0.023). However, the CEUS LI-RADS classification was not effective in distinguishing the predominance of the pathological cHCC-CCA components (P=0.283).

CONCLUSIONS

cHCC-CCAs classified as LR-M based on CEUS LI-RADS tend to be poorly differentiated, but the dominant pathologic component could be either HCC or ICC. cHCC-CCA lesions with ICC predominance were associated with early washout, whereas HCC-predominant lesions were associated with late washout. Additionally, the margins of HCC-predominant lesions were more ill-defined and irregular in shape compared to those of ICC-predominant lesions.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b8/11744172/c958ee148a71/qims-15-01-259-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b8/11744172/779ccd806ced/qims-15-01-259-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b8/11744172/884006f80883/qims-15-01-259-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b8/11744172/c958ee148a71/qims-15-01-259-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b8/11744172/779ccd806ced/qims-15-01-259-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b8/11744172/884006f80883/qims-15-01-259-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b8/11744172/c958ee148a71/qims-15-01-259-f3.jpg
摘要

背景

对比增强超声(CEUS)肝脏影像报告和数据系统(LI-RADS)分类为评估肝细胞癌(HCC)风险患者的肝脏病变提供了风险分层框架。然而,其在合并肝细胞癌-胆管癌(cHCC-CCA)中的临床应用尚未得到广泛研究。肿瘤分化程度在确定预后方面具有临床意义,因此分析不同分化水平的影像学特征至关重要。此外,研究表明cHCC-CCA病变中HCC和肝内胆管癌(ICC)成分的比例与其相应的影像学特征之间存在相关性。因此,本研究的目的是评估CEUS LI-RADS与cHCC-CCA的组织病理学成分和分化程度之间的关联。

方法

回顾性分析2020年4月至2023年4月间经病理证实的cHCC-CCA患者的病历和CEUS图像。通过组织病理学检查分析cHCC-CCA中HCC和ICC成分的优势及分化程度。采用卡方检验和双尾Student检验比较不同分化水平和病理成分在一般临床特征、超声特征和LI-RADS分类方面的差异。

结果

本研究共纳入47例cHCC-CCA患者,其中男性39例,女性8例,平均年龄56.±8.5岁。共分析47个病变。这些病变根据分化程度从低到高分类如下:20个病变(42.6%)为低分化,17个病变(36.2%)为中低分化,10个病变(21.3%)为中分化。分析了不同分化程度病变的CEUS特征。观察到较低的分化程度与更明显的早期洗脱相关(P=0.028),并且在CEUS LI-RADS分类系统下被分类为LR-M类别的可能性增加(P=0.043)。根据病理成分的优势,36个病变经病理证实以HCC为主,11个病变以ICC为主。分析了它们的超声特征,发现以ICC为主的cHCC-CCA病变更可能表现为形态规则(P=0.013)、边界清晰(P=0.010)且洗脱出现早(P=0.023)。然而,CEUS LI-RADS分类在区分cHCC-CCA病理成分的优势方面无效(P=0.283)。

结论

基于CEUS LI-RADS分类为LR-M的cHCC-CCA往往分化较差,但主要病理成分可能是HCC或ICC。以ICC为主的cHCC-CCA病变与早期洗脱相关,而以HCC为主的病变与晚期洗脱相关。此外,与以ICC为主的病变相比,以HCC为主的病变边界更不清晰且形态不规则。

相似文献

1
The correlation between contrast-enhanced ultrasound Liver Imaging Reporting and Data System classification and differentiation grades of combined hepatocellular carcinoma-cholangiocarcinoma.超声造影肝脏影像报告和数据系统分类与肝细胞癌-胆管癌合并症分化程度之间的相关性
Quant Imaging Med Surg. 2025 Jan 2;15(1):259-271. doi: 10.21037/qims-24-1483. Epub 2024 Dec 23.
2
Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?肝细胞癌-胆管细胞癌混合型:我们能否使用增强超声肝脏影像报告与数据系统(LI-RADS)来预测患者的生存情况?
Eur Radiol. 2021 Aug;31(8):6397-6405. doi: 10.1007/s00330-020-07656-1. Epub 2021 Jan 25.
3
Evaluation of combined hepatocellular-cholangiocarcinoma using CEUS LI-RADS: correlation with pathological characteristics.使用CEUS LI-RADS对肝内胆管癌-肝细胞癌混合型进行评估:与病理特征的相关性
Abdom Radiol (NY). 2025 Feb;50(2):646-655. doi: 10.1007/s00261-024-04519-x. Epub 2024 Aug 16.
4
Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?增强超声能区分肝内胆管细胞癌和肝细胞癌吗?
World J Gastroenterol. 2020 Jul 21;26(27):3938-3951. doi: 10.3748/wjg.v26.i27.3938.
5
Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018.在与磁共振场强匹配的高危患者中,鉴别肝细胞癌、肝内胆管细胞癌和肝细胞-胆管细胞癌:LI-RADS 版本 2018 的诊断性能。
Abdom Radiol (NY). 2021 Jul;46(7):3168-3178. doi: 10.1007/s00261-021-02996-y. Epub 2021 Mar 3.
6
How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?如何利用 LI-RADS 的 LR-M 特征提高钆塞酸增强 MRI 诊断混合细胞型肝癌?
Eur Radiol. 2019 May;29(5):2408-2416. doi: 10.1007/s00330-018-5893-1. Epub 2018 Dec 14.
7
CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma.对比增强超声和CT/MRI肝脏影像报告和数据系统联合血清生物标志物用于鉴别肝细胞癌合并胆管癌与肝细胞癌
Front Oncol. 2022 May 16;12:897090. doi: 10.3389/fonc.2022.897090. eCollection 2022.
8
Combined Hepatocellular-Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma.混合型肝细胞癌:基于肝细胞癌危险因素的磁共振成像特征和预后。
J Magn Reson Imaging. 2021 Jun;53(6):1803-1812. doi: 10.1002/jmri.27528. Epub 2021 Feb 9.
9
Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.肝细胞癌-胆管细胞癌混合型:钆塞酸增强磁共振成像的 LI-RADS v2017 分类用于鉴别诊断和预后评估。
Eur Radiol. 2019 Jan;29(1):373-382. doi: 10.1007/s00330-018-5605-x. Epub 2018 Jun 28.
10
Radiomics-Based Machine Learning Classification Strategy for Characterization of Hepatocellular Carcinoma on Contrast-Enhanced Ultrasound in High-Risk Patients with LI-RADS Category M Nodules.基于影像组学的机器学习分类策略用于对LI-RADS分类为M类结节的高危患者的超声造影肝细胞癌进行特征分析
Indian J Radiol Imaging. 2024 Jan 17;34(3):405-415. doi: 10.1055/s-0043-1777993. eCollection 2024 Jul.

本文引用的文献

1
MRI features of combined hepatocellular-cholangiocarcinoma.肝细胞-胆管细胞癌的磁共振成像特征
Abdom Radiol (NY). 2025 Jan;50(1):169-184. doi: 10.1007/s00261-024-04476-5. Epub 2024 Jul 20.
2
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.肝细胞-胆管细胞癌:生物学、诊断与管理
Liver Cancer. 2023 Apr 24;13(1):6-28. doi: 10.1159/000530700. eCollection 2024 Feb.
3
Update on the Diagnosis and Treatment of Combined Hepatocellular Cholangiocarcinoma.肝细胞胆管癌联合诊断与治疗的最新进展
J Clin Transl Hepatol. 2024 Feb 28;12(2):210-217. doi: 10.14218/JCTH.2023.00189. Epub 2023 Nov 15.
4
Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality.多区域分析合并肝细胞癌-胆管细胞癌揭示了组织学多样性和分子克隆性。
Histopathology. 2024 Jan;84(2):402-408. doi: 10.1111/his.15081. Epub 2023 Oct 30.
5
Performance of current versus modified CEUS LI-RADS in the diagnosis of non-hepatocellular carcinoma malignancies.现行与改良 CEUS LI-RADS 在诊断非肝细胞癌恶性肿瘤中的表现。
Abdom Radiol (NY). 2023 Dec;48(12):3688-3695. doi: 10.1007/s00261-023-04043-4. Epub 2023 Sep 19.
6
Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?-a direct head-to-head meta-analysis.与CT/MRI肝脏影像报告和数据系统(LI-RADS)相比,对比增强超声(CEUS)肝脏影像报告和数据系统在肝细胞癌诊断中是否值得推广?——一项直接的头对头荟萃分析。
Quant Imaging Med Surg. 2023 Aug 1;13(8):4919-4932. doi: 10.21037/qims-22-1383. Epub 2023 May 24.
7
LI-RADS LR-5 on contrast-enhanced ultrasonography has satisfactory diagnostic specificity for hepatocellular carcinoma: a systematic review and meta-analysis.超声造影检查中LI-RADS LR-5对肝细胞癌具有令人满意的诊断特异性:一项系统评价和荟萃分析。
Quant Imaging Med Surg. 2023 Feb 1;13(2):957-969. doi: 10.21037/qims-22-591. Epub 2023 Jan 10.
8
The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma.对比增强磁共振成像强化在肝细胞癌与肝内胆管癌鉴别诊断中的价值
J Oncol. 2022 Sep 15;2022:4691172. doi: 10.1155/2022/4691172. eCollection 2022.
9
Diagnostic value of CEUS LI-RADS and serum tumor markers for combined hepatocellular-cholangiocarcinoma.CEUS LI-RADS 及血清肿瘤标志物对肝细胞-胆管细胞癌的诊断价值。
Eur J Radiol. 2022 Sep;154:110415. doi: 10.1016/j.ejrad.2022.110415. Epub 2022 Jun 18.
10
Hepatocellular Carcinoma in Evolution: Correlation with CEUS LI-RADS.演变中的肝细胞癌:与 CEUS LI-RADS 的相关性。
Radiographics. 2022 Jul-Aug;42(4):1028-1042. doi: 10.1148/rg.210149. Epub 2022 Apr 29.